Monoclonal Antibody Therapy for B-Cell Malignancies

This publication has 95 references indexed in Scilit:

• ¹³¹I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
  New England Journal of Medicine, 2005
• Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011
  Blood, 2005
• FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia
  Blood, 2005
• Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma
  Journal of Clinical Oncology, 2004
• Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
  Cancer, 2003
• Rituximab plus chemotherapy in follicular and mantle cell lymphomas
  Seminars in Oncology, 2003
• Radioimmunotherapy of non-Hodgkin lymphomas
  Blood, 2003
• CNOP for Diffuse Aggressive Non-Hodgkin's Lymphoma: The Nebraska Lymphoma Study Group Experience
  Leukemia & Lymphoma, 2002
• Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1993
• Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype Antibody
  New England Journal of Medicine, 1982